These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 30467698
1. RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations. Khan MS, Qadri Q, Makhdoomi MJ, Wani MA, Malik AA, Niyaz M, Masoodi SR, Andrabi KI, Ahmad R, Mudassar S. Pathol Oncol Res; 2020 Jan; 26(1):507-513. PubMed ID: 30467698 [Abstract] [Full Text] [Related]
2. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications. Joung JY, Kim TH, Jeong DJ, Park SM, Cho YY, Jang HW, Jung YY, Oh YL, Yim HS, Kim YL, Chung JH, Ki CS, Kim SW. Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156 [Abstract] [Full Text] [Related]
3. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese. Liu RT, Chou FF, Wang CH, Lin CL, Chao FP, Chung JC, Huang CC, Wang PW, Cheng JT. Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154 [Abstract] [Full Text] [Related]
4. Novel rearrangements involving the RET gene in papillary thyroid carcinoma. Staubitz JI, Schad A, Springer E, Rajalingam K, Lang H, Roth W, Hartmann N, Musholt TJ. Cancer Genet; 2019 Jan; 230():13-20. PubMed ID: 30466862 [Abstract] [Full Text] [Related]
5. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F. J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191 [Abstract] [Full Text] [Related]
6. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis. Musholt TJ, Staubitz JI, Antonio Cámara RJ, Musholt PB, Humberg D, Springer E, Schad A. Eur J Surg Oncol; 2019 Jun; 45(6):1018-1024. PubMed ID: 30472213 [Abstract] [Full Text] [Related]
7. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation]. Zhu XL, Zhou XY, Zhang TM, Zhu XZ. Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482 [Abstract] [Full Text] [Related]
8. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Pekova B, Sykorova V, Dvorakova S, Vaclavikova E, Moravcova J, Katra R, Astl J, Vlcek P, Kodetova D, Vcelak J, Bendlova B. Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721 [Abstract] [Full Text] [Related]
9. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease. Su X, He C, Ma J, Tang T, Zhang X, Ye Z, Long Y, Shao Q, Shao J, Yang A. PLoS One; 2016 Dec; 11(11):e0165596. PubMed ID: 27802347 [Abstract] [Full Text] [Related]
10. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan). Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K, Muramatsu A, Ito K, Kobayashi M, Katoh R. Cancer; 2005 Sep 01; 104(5):943-51. PubMed ID: 16015630 [Abstract] [Full Text] [Related]
11. Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. Puxeddu E, Moretti S, Giannico A, Martinelli M, Marino C, Avenia N, Cristofani R, Farabi R, Reboldi G, Ribacchi R, Pontecorvi A, Santeusanio F. Eur J Endocrinol; 2003 May 01; 148(5):505-13. PubMed ID: 12720532 [Abstract] [Full Text] [Related]
12. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. Guerra A, Zeppa P, Bifulco M, Vitale M. Thyroid; 2014 Feb 01; 24(2):254-9. PubMed ID: 23806056 [Abstract] [Full Text] [Related]
13. 20 years of RET/PTC in thyroid cancer: clinico-pathological correlations. Fusco A, Santoro M. Arq Bras Endocrinol Metabol; 2007 Jul 01; 51(5):731-5. PubMed ID: 17891236 [Abstract] [Full Text] [Related]
14. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. Mechler C, Bounacer A, Suarez H, Saint Frison M, Magois C, Aillet G, Gaulier A. Br J Cancer; 2001 Dec 14; 85(12):1831-7. PubMed ID: 11747322 [Abstract] [Full Text] [Related]
15. [BRAFV599E mutation and RET/PTC rearrangements in papillary thyroid carcinoma]. Zhu XL, Zhou XY, Zhu XZ. Zhonghua Bing Li Xue Za Zhi; 2005 May 14; 34(5):270-4. PubMed ID: 16181547 [Abstract] [Full Text] [Related]
16. Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population. Wang Z, Yao Q, Bao L, Chang H, Ren M, Xue T, Wei R, Yu C, Wang Q, Wang Y, Ping B, Bai Q, Zhou X, Zhu X. Thyroid; 2024 Oct 14; 34(10):1260-1270. PubMed ID: 39212716 [Abstract] [Full Text] [Related]
18. Radiation exposure, young age, and female gender are associated with high prevalence of RET/PTC1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis. Su X, Li Z, He C, Chen W, Fu X, Yang A. Oncotarget; 2016 Mar 29; 7(13):16716-30. PubMed ID: 26918339 [Abstract] [Full Text] [Related]
19. Correlation Between the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated with Hashimoto's Thyroiditis, BRAF V600E Gene Mutation, and RET Gene Rearrangement. Xie M, Xu ZX, Dai M, Zhu YY. J Coll Physicians Surg Pak; 2024 Apr 29; 34(4):445-450. PubMed ID: 38576288 [Abstract] [Full Text] [Related]